Artificial Tears & Lubricating Eye Drops

The name artificial tears is slightly misleading. These products do not reproduce natural human tears. Natural tears are extraordinarily complex. They contain:

• •water
• •electrolytes
• •proteins
• •lipids
• •mucins
• •growth factors
• •antimicrobial molecules
• •and many other biologically active substances

An ordinary lubricating drop cannot recreate all of that. Instead, artificial tears are better thought of as ocular-surface supplements. They can temporarily:

• •increase lubrication
• •reduce friction
• •supplement tear volume
• •improve tear-film stability
• •and sometimes target particular tear-film deficiencies

TFOS DEWS III describes ocular supplements as a cornerstone of dry-eye management.

The Tear Film: what drops are supplementing

Sometimes they help address part of the tear-film problem. But often they primarily provide symptomatic and supportive treatment.

For example, if your lacrimal glands produce too little aqueous fluid, adding a lubricant can temporarily increase fluid on the ocular surface. But it does not necessarily make the lacrimal gland produce more. Similarly, if your meibomian glands are severely obstructed, a lipid-containing drop may temporarily supplement the tear film. But it does not necessarily correct the gland obstruction.

This distinction is important: improving the tear film is not always the same thing as correcting the reason it became abnormal.

That does not make artificial tears unimportant. Sometimes supporting the ocular surface while the underlying problem is being treated is exactly what is needed.

Because manufacturers can modify several properties of the formulation. For example:

• •viscosity, meaning how thick it is
• •retention, meaning how long it remains on the eye
• •osmolarity
• •lubricating polymer
• •lipid content
• •electrolyte composition
• •preservative system
• •and other ingredients

Different formulations therefore behave differently on the ocular surface. This is why asking “What is the best artificial tear?” is a little like asking “What is the best moisturizer?” The answer depends partly on what you are trying to accomplish.

Many artificial tears contain polymers that help lubricate the ocular surface and increase the time the drop remains there. Common examples include:

• •hyaluronic acid / sodium hyaluronate
• •carboxymethylcellulose (CMC)
• •hydroxypropyl methylcellulose / hypromellose
• •polyethylene glycol (PEG)
• •propylene glycol
• •hydroxypropyl guar
• •and related compounds

These ingredients differ in their physical properties. But an important point is that recognizing one ingredient on the label does not automatically tell you whether that product will work best for your eyes. The entire formulation matters.

Hyaluronic acid, often listed as sodium hyaluronate, is widely used in modern lubricating drops. It is a naturally occurring molecule with strong water-binding properties. In eye drops, it can increase lubrication and help the formulation remain on the ocular surface.

This is why you will see concentrations such as 0.1%, 0.15%, 0.2%, 0.3% and sometimes higher. It is tempting to assume that a higher percentage means a better drop. But that is not necessarily true. Concentration affects viscosity and retention, but the final behavior of a product also depends on its molecular characteristics and the rest of the formulation.

So a 0.3% hyaluronic-acid drop is not automatically “three times better” than a 0.1% drop.

One major difference is viscosity. A low-viscosity drop spreads easily and usually causes little visual blur. But it may also disappear relatively quickly. A more viscous formulation may remain on the ocular surface longer, which can be useful in more significant dryness. But the trade-off can be temporary blurred vision, stickiness, or simply an unpleasant sensation.

This gives us a useful principle: longer-lasting is not automatically better if the formulation becomes intolerable.

Gel-forming or highly viscous drops sit somewhere between ordinary artificial tears and ointments. They are designed to remain on the ocular surface longer than thin drops. They may be useful when ordinary drops provide relief but “five minutes later my eyes feel dry again.”

The disadvantage is that thicker formulations can temporarily blur vision. Some people therefore prefer them at home, in the evening or before sleep, rather than while driving or working visually.

Ointments are considerably thicker. They can provide prolonged lubrication and are therefore commonly used overnight. This can be particularly useful when symptoms occur during sleep or immediately after waking. But because ointments blur vision substantially, they are generally impractical for normal daytime activity.

Again, this is not stronger treatment versus weaker treatment. It is a different physical formulation for a different purpose.

Nocturnal Lagophthalmos: when the eyes don't fully close during sleep

Now we move to a different target. Some artificial tears contain lipid components designed to supplement the tear-film lipid layer. This can make sense when excessive evaporation is an important part of the problem, particularly in patients with MGD or lipid-layer deficiency. These formulations may contain different oils, phospholipids or lipid emulsions.

The principle is that an aqueous lubricant primarily supplements lubrication and fluid, while a lipid-containing formulation also attempts to support the evaporative barrier.

But lipid drops do not repair damaged meibomian glands. They supplement the tear film from outside. That distinction is worth repeating.

Lipid Deficiency

Not necessarily. MGD does not produce exactly the same tear-film abnormality in every patient. And someone with MGD can simultaneously have:

• •aqueous deficiency
• •mucin abnormalities
• •ocular-surface inflammation
• •or other problems

A lipid-containing drop may be useful when lipid deficiency and evaporation are relevant targets. But “MGD diagnosis, therefore lipid drops” is not a universal rule. The tear film needs to be considered as a whole.

In aqueous deficiency, adding fluid and lubrication has an obvious rationale. But again, artificial tears are replacement therapy. If natural tear production is substantially reduced, the effect of a drop may be temporary because the underlying deficiency remains.

This is why someone with severe aqueous deficiency may require drops very frequently or may need additional strategies such as:

• •tear conservation
• •tear stimulation
• •anti-inflammatory treatment
• •or more advanced ocular-surface protection

Artificial tears may be part of treatment without being the entire treatment.

Multi-dose eye-drop bottles can become contaminated after opening. Preservatives were traditionally added to prevent microbial growth. That makes sense from a product-safety perspective. But some preservatives can also affect the ocular surface. The best-known example is benzalkonium chloride (BAK).

With repeated exposure, particularly in already compromised ocular surfaces, preservatives can contribute to irritation and epithelial toxicity. For this reason, preservative-free formulations are often preferred when lubrication is required frequently.

No. This is another area where simple rules can become misleading. The effect depends on:

• •which preservative is used
• •its concentration
• •how frequently the drops are applied
• •and the condition of the ocular surface

Someone using a preserved drop occasionally is in a very different situation from someone putting it into severely compromised eyes ten or fifteen times per day.

So the useful question is not “Are preservatives toxic?” It is “How much preservative exposure is appropriate for this eye?”

Historically, preservative-free drops usually came in single-use vials. You opened one, used it and discarded it. But modern bottle designs can maintain sterility without conventional preservatives using:

• •special valves
• •filters
• •or other delivery systems

This allows preservative-free formulations to be sold in multidose bottles. So “multidose bottle” does not necessarily mean “contains preservative.” Always check the formulation.

This relates to the concentration of dissolved particles in the solution. Dry-eye disease can be associated with tear hyperosmolarity, an abnormally concentrated tear environment. Some artificial tears are therefore designed to be hypotonic, meaning their osmolarity is lower than that of the tear film they are entering. The idea is to help reduce excessive tear-film osmolarity.

Other formulations use osmoprotectants, molecules intended to help ocular-surface cells tolerate osmotic stress. These are different strategies aimed at the same general problem: protecting cells from the consequences of an abnormal tear environment.

Inflammation & Oxidative Stress: what hyperosmolarity sets in motion

Probably not. This is exactly where dry-eye treatment can become unnecessarily overwhelming. A patient should not need to become a formulation chemist.

Understanding the concept is useful because it explains why two bottles labelled “lubricating eye drops” may actually have quite different designs. But in practical terms, the more useful question is still: what tear-film problem are we trying to compensate for?

Because subjective response to artificial tears varies enormously. A formulation can differ in:

• •viscosity
• •pH
• •osmolarity
• •lipid content
• •preservatives
• •and other excipients

And your ocular surface may differ from someone else’s in:

• •tear volume
• •evaporation
• •epithelial damage
• •inflammation
• •corneal sensitivity
• •and many other ways

So another person’s “This is the only drop that works!” is useful anecdotal information. It is not evidence that the same formulation is ideal for you.

No convincing evidence supports one universally superior formulation. A Cochrane review examined 43 randomized or quasi-randomized trials involving 3,497 people and found that many artificial-tear formulations appeared to improve symptoms, but the overall evidence comparing individual formulations was low quality and did not establish one product as clearly superior for everyone.

This is actually reassuring. You do not necessarily need to find a secret miracle brand. The goal is to find a formulation that suits your particular tear-film problem and your eyes.

Artificial tears do not normally create a physiological addiction in which the lacrimal gland “forgets” how to produce tears because drops are being used. But there is another phenomenon that can look like dependence.

Suppose your underlying dry eye remains untreated. The drop makes you comfortable. The effect wears off. Your original symptoms return. You use another drop. That can feel like “My eyes have become dependent on drops.” But what may actually be happening is that the treatment is temporary while the underlying problem persists.

That distinction is important.

Frequent use can sometimes be appropriate, particularly in severe disease and especially with preservative-free products. But needing lubrication extremely frequently is also information. It may indicate that simple tear supplementation is not adequately addressing the underlying problem.

Instead of only asking “Which drop lasts longer?” it may be worth asking: why is my tear film failing this quickly? Is there:

• •severe aqueous deficiency?
• •rapid evaporation?
• •significant inflammation?
• •exposure?
• •poor blinking?
• •ocular-surface damage?
• •or another contributor?

The frequency of drop use can itself tell us something about disease control.

Blink & Eyelid Closure Problems

There is no universal answer. In some patients, regular lubrication may help maintain a more stable ocular-surface environment rather than waiting until symptoms become severe. Others may only need occasional supplementation. Severity, formulation and treatment goals matter.

But one thing is worth remembering: symptoms are not a perfect real-time measurement of ocular-surface condition. Some people can have significant surface abnormalities with surprisingly modest symptoms, while others can have severe symptoms with relatively limited visible staining. So treatment decisions should not always depend exclusively on “Do my eyes feel dry right now?”

Normal blinking and tear drainage already create a constantly changing tear environment. Artificial tears temporarily mix with and alter that environment. There is no good reason to imagine that appropriate use of preservative-free lubricants simply “washes away” all beneficial natural tear components and thereby causes dry eye.

However, endlessly increasing drop frequency is not necessarily the solution if the underlying disease remains uncontrolled. Again, the question becomes: why do I need them this often?

Some formulations may support epithelial recovery by:

• •reducing friction
• •improving lubrication
• •reducing osmotic stress
• •and creating a more favorable surface environment

But standard artificial tears are not equivalent to biological tear substitutes such as autologous serum or platelet-derived products, which contain biologically active components not present in ordinary lubricants.

So “lubrication can support healing” is reasonable. “Artificial tears reproduce all the healing properties of natural tears” is not.

Autologous Serum & Other Blood-Derived Eye Drops

The tear film is the first optical surface that light encounters when entering the eye. An irregular or unstable tear film can therefore degrade visual quality. A lubricating drop may temporarily create a smoother, more stable optical surface.

This is why some people with dry eye experience fluctuating vision that improves temporarily after blinking or applying drops. The effect is not simply “my eye feels wetter.” The tear film is part of the eye’s optical system.

Because a thicker drop temporarily changes that optical surface too. Viscous gels, lipid emulsions and ointments may initially create blur before distributing across the eye. So temporary blur immediately after application does not necessarily mean the product is damaging the eye. It may simply reflect its physical properties.

Persistent or unusual visual changes, however, deserve evaluation rather than being automatically attributed to dry eye.

Trying different formulations can be reasonable. But endless trial-and-error becomes less useful if nobody has identified the main tear-film abnormality. A more rational sequence is:

What is deficient?→What type of formulation targets that problem?→Can I tolerate it?→Does it meaningfully improve comfort, stability or function?

That narrows the search considerably.

You do not need to memorize every ingredient. For most people, a few questions are enough:

• •Is it preservative-free?
• •Is it a thin drop, viscous drop, gel or ointment?
• •Does it contain a lipid component?
• •What is the main lubricating polymer?
• •How frequently am I likely to use it?

Then connect those answers to the treatment target. For example:

• •frequent daytime lubrication: a preservative-free, tolerable formulation
• •significant evaporation or lipid deficiency: consider a lipid-containing formulation
• •very short duration of ordinary drops: consider greater viscosity
• •night-time exposure or dryness: a gel or ointment may provide longer protection

Those are starting principles, not rigid rules.

Do not judge them only by “Do they feel soothing when I put them in?” Ask:

• •How long does the effect last?
• •Do I need them less frequently over time?
• •Does my vision fluctuate less?
• •Can I use screens longer?
• •Can I tolerate wind or air conditioning better?
• •Is ocular-surface staining improving?
• •Is tear-film stability improving?

And perhaps most importantly: are the drops supporting recovery, or are they the only thing keeping an untreated problem temporarily tolerable? Those are very different situations.

How to Choose a Dry Eye Treatment